These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 25089547)

  • 1. Long-term outcome of inflammatory bowel diseases with cytomegalovirus colitis: effect of antiviral treatment.
    Maconi G; Lombardini M; Furfaro F; Bezzio C; Zerbi P; Ardizzone S
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1146-51. PubMed ID: 25089547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
    Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
    Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of cytomegalovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study.
    Kim YS; Kim YH; Kim JS; Jeong SY; Park SJ; Cheon JH; Ye BD; Jung SA; Park YS; Choi CH; Kim KO; Jang BI; Han DS; Yang SK; Kim WH
    Gut Liver; 2014 Nov; 8(6):643-7. PubMed ID: 25368753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.
    Pillet S; Pozzetto B; Roblin X
    World J Gastroenterol; 2016 Feb; 22(6):2030-45. PubMed ID: 26877608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis.
    Clos-Parals A; Rodríguez-Martínez P; Cañete F; Mañosa M; Ruiz-Cerulla A; José Paúles M; Llaó J; Gordillo J; Fumagalli C; Garcia-Planella E; Ojanguren I; Cabré E; Guardiola J; Domènech E
    J Crohns Colitis; 2019 Mar; 13(3):385-388. PubMed ID: 30346606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status.
    Inokuchi T; Kato J; Hiraoka S; Suzuki H; Nakarai A; Hirakawa T; Akita M; Takahashi S; Harada K; Okada H; Yamamoto K
    World J Gastroenterol; 2014 Jan; 20(2):509-17. PubMed ID: 24574719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis.
    Roblin X; Pillet S; Oussalah A; Berthelot P; Del Tedesco E; Phelip JM; Chambonnière ML; Garraud O; Peyrin-Biroulet L; Pozzetto B
    Am J Gastroenterol; 2011 Nov; 106(11):2001-8. PubMed ID: 21788989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection.
    Maconi G; Colombo E; Zerbi P; Sampietro GM; Fociani P; Bosani M; Cassinotti A; Casini V; Russo A; Ardizzone S; Porta M; Bianchi Porro G
    Dig Liver Dis; 2005 Jun; 37(6):418-23. PubMed ID: 15893280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis.
    Okahara K; Nagata N; Shimada T; Joya A; Hayashida T; Gatanaga H; Oka S; Sakurai T; Uemura N; Akiyama J
    PLoS One; 2017; 12(9):e0183951. PubMed ID: 28886066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus colitis in hospitalized inflammatory bowel disease patients in Taiwan: a referral center study.
    Weng MT; Tung CC; Lee YS; Leong YL; Shieh MJ; Shun CT; Wang CY; Wong JM; Wei SC
    BMC Gastroenterol; 2017 Feb; 17(1):28. PubMed ID: 28193173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. True cytomegalovirus colitis is a poor prognostic indicator in patients with ulcerative colitis flares: the 10-year experience of an academic referral inflammatory bowel disease center.
    Oh SJ; Lee CK; Kim YW; Jeong SJ; Park YM; Oh CH; Kim JW; Kim HJ
    Scand J Gastroenterol; 2019 Aug; 54(8):976-983. PubMed ID: 31356759
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytomegalovirus infection and postoperative complications in patients with ulcerative colitis undergoing colectomy.
    Olaisen M; Rydning A; Martinsen TC; Nordrum IS; Mjønes P; Fossmark R
    Scand J Gastroenterol; 2014 Jul; 49(7):845-52. PubMed ID: 24947587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease.
    Delvincourt M; Lopez A; Pillet S; Bourrier A; Seksik P; Cosnes J; Carrat F; Gozlan J; Beaugerie L; Roblin X; Peyrin-Biroulet L; Sokol H
    Aliment Pharmacol Ther; 2014 Apr; 39(7):712-20. PubMed ID: 24506221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy for cytomegalovirus.
    Jones A; McCurdy JD; Loftus EV; Bruining DH; Enders FT; Killian JM; Smyrk TC
    Clin Gastroenterol Hepatol; 2015 May; 13(5):949-55. PubMed ID: 25283582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients.
    Matsuoka K; Iwao Y; Mori T; Sakuraba A; Yajima T; Hisamatsu T; Okamoto S; Morohoshi Y; Izumiya M; Ichikawa H; Sato T; Inoue N; Ogata H; Hibi T
    Am J Gastroenterol; 2007 Feb; 102(2):331-7. PubMed ID: 17156136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies.
    Yoshino T; Nakase H; Ueno S; Uza N; Inoue S; Mikami S; Matsuura M; Ohmori K; Sakurai T; Nagayama S; Hasegawa S; Sakai Y; Chiba T
    Inflamm Bowel Dis; 2007 Dec; 13(12):1516-21. PubMed ID: 17828781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases.
    Lévêque N; Brixi-Benmansour H; Reig T; Renois F; Talmud D; Brodard V; Coste JF; De Champs C; Andréoletti L; Diebold MD
    J Med Virol; 2010 Oct; 82(10):1694-700. PubMed ID: 20827767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.
    Kopylov U; Papamichael K; Katsanos K; Waterman M; Bar-Gil Shitrit A; Boysen T; Portela F; Peixoto A; Szilagyi A; Silva M; Maconi G; Har-Noy O; Bossuyt P; Mantzaris G; Barreiro de Acosta M; Chaparro M; Christodoulou DK; Eliakim R; Rahier JF; Magro F; Drobne D; Ferrante M; Sonnenberg E; Siegmund B; Muls V; Thurm T; Yanai H; Dotan I; Raine T; Levin A; Israeli E; Ghalim F; Carbonnel F; Vermeire S; Ben-Horin S; Roblin X
    Inflamm Bowel Dis; 2017 Sep; 23(9):1605-1613. PubMed ID: 28590343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
    Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
    Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis.
    Pillet S; Jarlot C; Courault M; Del Tedesco E; Chardon R; Saint-Sardos P; Presles E; Phelip JM; Berthelot P; Pozzetto B; Roblin X
    Inflamm Bowel Dis; 2015 Jul; 21(7):1580-6. PubMed ID: 25933392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.